119 related articles for article (PubMed ID: 12182875)
1. Design, synthesis and biological evaluation of cyclic angiotensin II analogues with 3,5 side-chain bridges. Role of C-terminal aromatic residue and ring cluster for activity and implications in the drug design of AT1 non-peptide antagonists.
Roumelioti P; Polevaya L; Zoumpoulakis P; Giatas N; Mutule I; Keivish T; Zoga A; Vlahakos D; Iliodromitis E; Kremastinos D; Grdadolnik SG; Mavromoustakos T; Matsoukas J
Bioorg Med Chem Lett; 2002 Sep; 12(18):2627-33. PubMed ID: 12182875
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and study of a cyclic angiotensin II antagonist analogue reveals the role of pi*--pi* interactions in the C-terminal aromatic residue for agonist activity and its structure resemblance with AT(1) non-peptide antagonists.
Polevaya L; Mavromoustakos T; Zoumboulakis P; Golic Grdadolnik S; Roumelioti P; Giatas N; Mutule I; Keivish T; Vlahakos DV; Iliodromitis EK; Kremastinos DT; Matsoukas J
Bioorg Med Chem; 2001 Jun; 9(6):1639-47. PubMed ID: 11408184
[TBL] [Abstract][Full Text] [Related]
3. The design and synthesis of a potent Angiotensin II cyclic analogue confirms the ring cluster receptor conformation of the hormone Angiotensin II.
Matsoukas JM; Polevaya L; Ancans J; Mavromoustakos T; Kolocouris A; Roumelioti P; Vlahakos DV; Yamdagni R; Wu Q; Moore GJ
Bioorg Med Chem; 2000 Jan; 8(1):1-10. PubMed ID: 10968258
[TBL] [Abstract][Full Text] [Related]
4. Vinyl sulfide cyclized analogues of angiotensin II with high affinity and full agonist activity at the AT(1) receptor.
Johannesson P; Lindeberg G; Johansson A; Nikiforovich GV; Gogoll A; Synnergren B; Le Grèves M; Nyberg F; Karlén A; Hallberg A
J Med Chem; 2002 Apr; 45(9):1767-77. PubMed ID: 11960488
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of angiotensin II and Sarmesin analogues containing cyclohexylalanine.
Hondrelis J; Matsoukas J; Cordopatis P; Ganter RC; Franklin KJ; Moore GJ
Int J Pept Protein Res; 1991 Jan; 37(1):21-6. PubMed ID: 2045217
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological activities of four angiotensin II receptor ligands with gamma-turn mimetics replacing amino acid residues 3-5.
Schmidt B; Lindman S; Tong W; Lindeberg G; Gogoll A; Lai Z; Thörnwall M; Synnergren B; Nilsson A; Welch CJ; Sohtell M; Westerlund C; Nyberg F; Karlén A; Hallberg A
J Med Chem; 1997 Mar; 40(6):903-19. PubMed ID: 9083479
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophan.
Matsoukas JM; Goghari MH; Scanlon MN; Franklin KJ; Moore GJ
J Med Chem; 1985 Jun; 28(6):780-3. PubMed ID: 4009600
[TBL] [Abstract][Full Text] [Related]
8. Role of the NH2-terminal domain of angiotensin II (ANG II) and [Sar1]angiotensin II on conformation and activity. NMR evidence for aromatic ring clustering and peptide backbone folding compared with [des-1,2,3]angiotensin II.
Matsoukas JM; Hondrelis J; Keramida M; Mavromoustakos T; Makriyannis A; Yamdagni R; Wu Q; Moore GJ
J Biol Chem; 1994 Feb; 269(7):5303-12. PubMed ID: 8106515
[TBL] [Abstract][Full Text] [Related]
9. Receptor interactions of the position 4 side chains of angiotensin II analogues: importance of aromatic ring quadrupole.
Moore GJ; Ganter RC; Matsoukas JM; Hondrelis J; Agelis G; Barlos K; Wilkinson S; Sandall J; Fowler P
J Mol Recognit; 1994 Dec; 7(4):251-6. PubMed ID: 7734150
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel antihypertensive drugs.
Moutevelis-Minakakis P; Gianni M; Stougiannou H; Zoumpoulakis P; Zoga A; Vlahakos AD; Iliodromitis E; Mavromoustakos T
Bioorg Med Chem Lett; 2003 May; 13(10):1737-40. PubMed ID: 12729654
[TBL] [Abstract][Full Text] [Related]
11. Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP).
Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M; Erdélyi M; Hallberg A
J Med Chem; 2010 Nov; 53(22):8059-71. PubMed ID: 21047126
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II analogues with sulphur-containing side-chains in position 5. A structure-activity relationship study.
Pérodin J; Bouley R; Escher E; Assimomytis N; Magafa V; Manessi-Zoupa E; Theodoropoulos D; Cordopatis P
Arzneimittelforschung; 2000 Jun; 50(6):526-9. PubMed ID: 10918944
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships for the competitive angiotensin antagonist [sarcosine,O-methyltyrosine4]angiotensin II (sarmesin).
Goghari MH; Franklin KJ; Moore GJ
J Med Chem; 1986 Jun; 29(6):1121-4. PubMed ID: 3754902
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a specific binding site for angiotensin II in chicken liver.
Bouley R; Gosselin M; Plante H; Servant G; Pérodin J; Arcand M; Guillemette G; Escher E
Can J Physiol Pharmacol; 1997 Jun; 75(6):568-75. PubMed ID: 9276130
[TBL] [Abstract][Full Text] [Related]
15. Rational design, efficient syntheses and biological evaluation of N,N'-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers.
Agelis G; Resvani A; Koukoulitsa C; Tůmová T; Slaninová J; Kalavrizioti D; Spyridaki K; Afantitis A; Melagraki G; Siafaka A; Gkini E; Megariotis G; Grdadolnik SG; Papadopoulos MG; Vlahakos D; Maragoudakis M; Liapakis G; Mavromoustakos T; Matsoukas J
Eur J Med Chem; 2013 Apr; 62():352-70. PubMed ID: 23376252
[TBL] [Abstract][Full Text] [Related]
16. Comparison of three gamma-turn mimetic scaffolds incorporated into angiotensin II.
Lindman S; Lindeberg G; Nyberg F; Karlén A; Hallberg A
Bioorg Med Chem; 2000 Sep; 8(9):2375-83. PubMed ID: 11026551
[TBL] [Abstract][Full Text] [Related]
17. Structural comparison between type I and type II antagonists: possible implications in the drug design of AT1 antagonists.
Roumelioti P; Tselios T; Alexopoulos K; Mavromoustakos T; Kolocouris A; Moore GJ; Matsoukas JM
Bioorg Med Chem Lett; 2000 Apr; 10(8):755-8. PubMed ID: 10782679
[TBL] [Abstract][Full Text] [Related]
18. Design of potent dicyclic (4-10/5-8) gonadotropin releasing hormone (GnRH) antagonists.
Rivier JE; Struthers RS; Porter J; Lahrichi SL; Jiang G; Cervini LA; Ibea M; Kirby DA; Koerber SC; Rivier CL
J Med Chem; 2000 Mar; 43(5):784-96. PubMed ID: 10715147
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
Schiller PW; Nguyen TM; Lemieux C; Maziak LA
J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
[TBL] [Abstract][Full Text] [Related]
20. Novel synthesis of cyclic amide-linked analogues of angiotensins II and III.
Matsoukas JM; Hondrelis J; Agelis G; Barlos K; Gatos D; Ganter R; Moore D; Moore GJ
J Med Chem; 1994 Sep; 37(18):2958-69. PubMed ID: 8071943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
